These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19699358)

  • 1. Seasonal variation in lipids: should we consider it more?
    Manfredini R; Salmi R; Boari B; Manfredini F
    Am J Cardiol; 2009 Sep; 104(5):739-40. PubMed ID: 19699358
    [No Abstract]   [Full Text] [Related]  

  • 2. Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study).
    Tung P; Wiviott SD; Cannon CP; Murphy SA; McCabe CH; Gibson CM
    Am J Cardiol; 2009 Apr; 103(8):1056-60. PubMed ID: 19361589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].
    Einecke D
    MMW Fortschr Med; 2003 Dec; 145(51-52):38. PubMed ID: 14974329
    [No Abstract]   [Full Text] [Related]  

  • 4. Pleiotropic effects of statins and early benefit in the PROVE IT-TIMI-22 study.
    Poli A; Pujia A
    J Am Coll Cardiol; 2006 Aug; 48(4):852; author reply 852-3. PubMed ID: 16904573
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-density lipoprotein lowering and atherosclerosis progression: does more mean less?
    Shah PK
    Circulation; 2002 Oct; 106(16):2039-40. PubMed ID: 12379568
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid management: considerations in acute coronary syndrome.
    Polsani VR; Virani SS; Nambi V
    Curr Cardiol Rep; 2008 Jul; 10(4):334-41. PubMed ID: 18611369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genetic variants associated with response to statin therapy.
    Mega JL; Morrow DA; Brown A; Cannon CP; Sabatine MS
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1310-5. PubMed ID: 19667110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).
    Khera AV; Wolfe ML; Cannon CP; Qin J; Rader DJ
    Am J Cardiol; 2010 Aug; 106(4):451-6. PubMed ID: 20691300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].
    Einecke D
    MMW Fortschr Med; 2006 Jun; 148(24):4-5. PubMed ID: 16850796
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications for statin therapy in patients with acute coronary syndrome of ischemic origin].
    Raddino R; Della Pina P; Gorga E; Caretta G; Madureri A; Dei Cas L
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):78S-83S. PubMed ID: 21416832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torcetrapib and atorvastatin.
    Shear CL
    N Engl J Med; 2005 Oct; 353(14):1527-9; author reply 1527-9. PubMed ID: 16207861
    [No Abstract]   [Full Text] [Related]  

  • 13. An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).
    Smith DG; McBurney CR
    Pharmacoeconomics; 2003; 21 Suppl 1():13-23. PubMed ID: 12648031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy and the elderly: SAGE advice?
    Gotto AM
    Circulation; 2007 Feb; 115(6):681-3. PubMed ID: 17296867
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comment from the cardiologic viewpoint].
    Lüscher TF
    Praxis (Bern 1994); 2009 Feb; 98(3):129-30. PubMed ID: 19180438
    [No Abstract]   [Full Text] [Related]  

  • 16. Noninferiority of pitavastatin in intravascular ultrasound findings.
    Kaneda H; Ma J; Morita T
    J Am Coll Cardiol; 2010 Jan; 55(3):262-3; author reply 263. PubMed ID: 20117416
    [No Abstract]   [Full Text] [Related]  

  • 17. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
    Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
    N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for high-risk patients without heart disease or high cholesterol.
    Med Lett Drugs Ther; 2006 Jan; 48(1225):1-3. PubMed ID: 16374400
    [No Abstract]   [Full Text] [Related]  

  • 19. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
    März W
    MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673
    [No Abstract]   [Full Text] [Related]  

  • 20. Antilipid agents may provide allergy protection.
    Rosenberg JL
    Ann Allergy Asthma Immunol; 2013 Jan; 110(1):1. PubMed ID: 23244649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.